Show simple item record

Imatinib mesylate in the management of chemotherapy-induced pulmonary toxicity: a double-edged sword.

dc.contributor.authorEskazan, AHMET EMRE
dc.date.accessioned2021-03-06T13:18:01Z
dc.date.available2021-03-06T13:18:01Z
dc.identifier.citationEskazan A. E. , "Imatinib mesylate in the management of chemotherapy-induced pulmonary toxicity: a double-edged sword.", Acta oncologica (Stockholm, Sweden), cilt.58, ss.123-124, 2019
dc.identifier.issn0284-186X
dc.identifier.othervv_1032021
dc.identifier.otherav_f80316e2-0935-4451-9908-4ec5c2edf9d4
dc.identifier.urihttp://hdl.handle.net/20.500.12627/162429
dc.identifier.urihttps://doi.org/10.1080/0284186x.2018.1502469
dc.language.isoeng
dc.titleImatinib mesylate in the management of chemotherapy-induced pulmonary toxicity: a double-edged sword.
dc.typeMakale
dc.relation.journalActa oncologica (Stockholm, Sweden)
dc.contributor.departmentİstanbul Üniversitesi , Açık ve Uzaktan Eğitim Fakültesi , Coğrafya
dc.identifier.volume58
dc.identifier.startpage123
dc.identifier.endpage124
dc.contributor.firstauthorID180457


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record